03-28-2014          FDA moves to offset shortage of common saline solution
01-31-2014          U.S. FDA investigates risks from testosterone
12-06-2013          UK cost agency recommends teriflunomide (Aubagio) for MS
10-18-2013          UK cost agency backs enzalutamide for prostate cancer
05-15-2013          FDA approves new drug for prostate cancer
05-02-2013          FDA panel votes against tivozanib for kidney cancer
04-30-2013          FDA staff to ask panel if tivozanib for kidney cancer needs more study
03-28-2013          Pfizer gets rebuff from UK cost body for axitinib (Inlyta)
01-25-2013          FDA approves OTC version of overactive bladder drug
09-04-2012          Axitinib gets EU approval for refractory kidney cancer
08-31-2012          FDA approves enzalutamide for late-stage prostate cancer
06-28-2012          U.S. FDA approves Myrbetriq (mirabegron) for overactive bladder
06-11-2012          UK watchdog revises Xgeva (denosumab) guidance in prostate cancer
05-16-2012          Britain to fund prostate cancer drug Zytiga (abiraterone) in U-turn
04-27-2012          FDA rejects Xgeva for preventing prostate CA spread to bone
04-26-2012          FDA approves drug for tuberous sclerosis complex kidney tumors
04-13-2012          Anemia drug Omontys (peginesatide) gets reimbursement code
04-12-2012          Sexual side effect warnings added to finasteride
04-09-2012          FDA program to foster innovation starts with kidneys
04-05-2012          U.S. FDA panel backs drug for leaky bladder
04-03-2012          FDA staff focus on safety of new Astellas bladder drug
03-27-2012          U.S. FDA approves Affymax anemia treatment
02-10-2012          US FDA issues plan to avoid heparin contamination
02-08-2012          U.S. FDA panel votes against extending use of Amgen drug
02-02-2012          UK says home-grown cancer pill too costly to use
01-30-2012          U.S. FDA approves Inlyta (axitinib) for refractory kidney cancer
01-25-2012          Cholesterol drug Vytorin gets new label, but not new indication
01-17-2012          FDA approves BTG's drug for methotrexate toxicity